Due to ongoing labour disputes, Canada Post services will be suspended, which may impact some of our FIT and Integrative Laboratory Services (ILS) clients. Read more
Back to Test Catalogue

Everolimus (LC-MS/MS), Blood

Test ID: EVERO WB

Test

Method

Chromatography/Mass Spectrometry

Report Includes

Everolimus

Specimens

Whole blood (EDTA)

Test Location

Quest Diagnostics, Virginia USA

Test Version

17-Mar-2023

Specimen

Specimens

Whole blood (EDTA)

Collection Containers

Lavender top (EDTA)

Sample Volume

2 mL

Minimum Volume

1 mL

Collection & Handling

Handling Information

Drug regimens are to be noted on requisition: Time and date of drug administration.Therapeutic range applies to trough specimens drawn just prior to a.m. dose.

Stability

Ambient 7 days
Refrigerated 14 days
Frozen 30 days

Additional Stability Information

Store and send cold or frozen.

Rejection Criteria

Specimen Gel-separator tube or Clotted specimens

Test Version

17-Mar-2023

Performance / Interpretation

Method

Chromatography/Mass Spectrometry

Turnaround Time

11 days

Results

Name Units Reference Range Conversion Factor
Everolimus, LC/MS/MS, Blood ng/mL
  • Trough 3.0 - 8.0 for Transplantation
  • Trough 5.0 - 10.0 for Oncology/Neurology
Symptoms of toxicity are more likely to occur at trough levels exceeding 12.0 ng/mL

Test Location

Quest Diagnostics, Virginia USA

Test Version

17-Mar-2023

Interface / Setup

HL7 Interface Codes

Order Code Result Codes Units
EVERO WB 63548EVEROLIMUS,LC/MS/MS,BLOOD ng/mL

Test Version

17-Mar-2023